[A comparative clinical study of modified IA "3+4" regimen and intermediate-dose cytarabine regimen in the consolidation treatment of low-risk acute myeloid leukemia]
[改良IA“3+4”方案与中等剂量阿糖胞苷方案在低危急性髓系白血病巩固治疗中的比较临床研究]
期刊:Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
影响因子:
doi:10.3760/cma.j.issn.0253-2727.2022.07.011
Liu, X H; Jia, J S; Wang, J; Gong, L Z; Tang, F F; Yu, W J; Zhu, X L; Wang, Y; Jiang, Q; Chang, Y J; Zhao, X S; Ruan, G R; Qin, Y Z; Huang, X J; Jiang, H